Plavin Stephen D reported option exercise involving 10,874 derivative units of Cushman Wakefield Ltd. at $0.00 for $0 on Oct 1, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Oct 2, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
10,874Restricted Stock Units
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
Oct 1, 2026Option exercise
Filed
Oct 2, 2026, 4:07 PM ET1-day reporting delay
Accession
0001628369-26-000128Code M · Transaction 234313
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Oct 1, 2026Option exercise10,874$12.06$131,140.44Trade 234312
2 transaction rows in this filing. Joint filers share the same rows.

CWK price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CWK · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +12%1w ago +3%1d ago −0.9%
Returns since7d −2.5%30d +12%90d180d1y

Footnotes in full

F1: Conversion of previously awarded restricted stock units ("RSUs") into an equal number of common shares, without the payment of any consideration, pursuant to the Third Amended & Restated 2018 Omnibus Non-Employee Director Share and Cash Incentive Plan. F2: RSUs were granted on October 1, 2025 and vested and settled on October 1, 2026.